The Telomerase Inhibitor Imetelstat Alone, and in Combination With Trastuzumab, Decreases the Cancer Stem Cell Population and Self-Renewal of HER2+ Breast Cancer Cells

Breast Cancer Research and Treatment - Netherlands
doi 10.1007/s10549-015-3270-1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC


Related search